ANI Pharmaceuticals | ANIP - Interest Expense On Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

ANI Pharmaceuticals

ANI Pharmaceuticals reported $7.7M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.


Interest Expense On Debt Change
ANI Pharmaceuticals ANIP:US USD 7.7M 190K
Eli Lilly LLY:US USD 102.8M 18.8M
Endo International ENDP:US USD 263K 540K
Knight Therapeutics Inc GUD:CN CAD 2.79M 498K
Nektar Therapeutics NKTR:US USD 6.4M 796K
Novartis NVS:US USD 211M 8M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 260M 23M